Koyfin Home > Directory > Health Care > Antares Pharma > Total Debt / EBITDA

Antares Pharma Total Debt / EBITDA Chart (ATRS)

Antares Pharma annual/quarterly Total Debt / EBITDA from 2019 to 2019.
Other Ratios Metrics:
  • Antares Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $39m a -19.64% decrease of -8m year over year
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
  • Antares Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $64m a -36.97% decrease of -24m year over year
View Chart On Koyfin